ArticleOncotarget2018

Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development.

Julia Schueler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.